Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
NCT04822584
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Vitiligo
Interventions
DRUG:
Baricitinib Oral Product
DRUG:
Placebo
Sponsor
University Hospital, Bordeaux